Research
1. Viral Assembly & Antiviral Strategies & Advanced Biotechnology
We investigate the critical stage of the viral replication cycle: how hundreds of structural proteins interact with viral RNA to assemble into new infectious particles. By deciphering the structural and functional mechanics of these interactions, we aim to design targeted inhibitors that block viral assembly and halt infection. We also focus on the production of advanced peptide-based therapeutics.
Retroviruses: We study RNA-to-DNA reverse-transcribing viruses, with a primary focus on HIV.
Flaviviruses: We research severe global and regional pathogens, including the Dengue, Zika, and Tick-borne encephalitis (TBE) viruses.
Next-Generation Peptides: Production of advanced peptide-based drugs and therapeutics containing non-canonical amino acids by Genetic code expansion using in vitro (Cell-Free Protein Synthesis - CFPS) and in vivo methods.
Key Techniques: To study these complex processes, we routinely employ a broad spectrum of molecular and cellular methods, including DNA/RNA isolation, molecular cloning, mutagenesis, tissue culture techniques, qPCR, Western Blotting (WB), Fast Protein Liquid Chromatography (FPLC), FACS, ELISA, CRISPR techniques and more.
Explore our publications and learn more about our research.
Highlighted
All
2026
2025
2024